Trichomoniasis is the most common curable sexually transmitted disease in the U.S., affecting approximately 3.7 million people, often without noticeable symptoms. The infection primarily affects women and can lead to increased risks of preterm birth and HIV transmission, while men typically experience mild symptoms or none at all. Treatment options include metronidazole and tinidazole, with emphasis on testing and treating sexual partners to prevent reinfection.